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A R T I C L E   I N F O S U M M A R Y 
Indomethacin and piroxicam are known to become amorphous upon rapid cooling 
after melting. Multiple three-component co-amorphous mixtures have been 
produced via a melt quench method to evaluate the influence of the third component 
on stability and physical properties on the co-amorphous mixture of piroxicam and 
indomethacin. These have then been tested using thermal gravimetric analysis, 
differential scan calorimetry and hot stage microscopy. Results have confirmed the 
creation of a three-component co-amorphous system. 
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INTRODUCTION 
Amorphous materials are characterised by short 
range structural order, although this solid state is 
characterised by thermodynamic instability 
(conversion to crystalline) amorphous forms of active 
pharmaceutical ingredients (APIs) are often preferred 
over their crystalline counterparts because of their 
better dissolution rate (Fahlman, 2011). 
Amorphous dispersion of amorphous materials is 
defined as a co-amorphous mixture (Dengale, 2016). 
A co-amorphous system is primarily identified by one 
glass transition indicating that the systems are 
miscible and are interacting. Multiple component co-
amorphous systems may allow certain properties to 
be manipulated giving benefits such as improved 
dissolution rates, higher glass transition temperatures 
and increased stability.  
This work aims to identify if a three component co- 
amorphous system can be created reliably using a 
melt quench method. 
MATERIALS AND METHODS 
Piroxicam (PXC) and indomethacin (IND) were 
chosen as preliminary testing showed that the pure 
compounds formed stable amorphous materials with 
glass transition temperatures above room 
temperature. 
The third components were also chosen from 
preliminary tests, two were chosen as they showed a 
strong tendency to crystallise on cooling (benzamide 
(BZD), caffeine (CAF)) another two were chosen as 
they showed a propensity towards amorphicity on 
cooling (acetaminophen (AC), clotrimazole (CTMZ)). 
Physical mixtures were prepared in a 1:1:1 molar ratio. 
The production of amorphous samples was 
conducted by melting and cooling within the DSC 
instrument. The DSC pans were then opened and the 
sample was removed for analysis. Before analysis, all 
samples were finely ground using mortar and pestle 
to ensure a homogenous distribution of components 
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and to reduce the possibility of thermal lag within 
larger particles. 
Thermo-gravimetric analysis (TGA) was conducted 
using the Q5000 IR TGA (TA Instruments, UK) in 
aluminium pans with sample size 2.0 ± 0.5 mg. 
Samples were heated from ambient temperature to 
300°C at 10°C/min, under nitrogen (25 ml/min). 
Hot-stage microscopy (HSM) was conducted using a 
Mettler Toledo FP90 Central processor with a FP82HT 
Hot Stage. The heating program used was 10°C/min 
from 30℃ to 300°C. This allowed the visual 
identification of thermal events (melting, 
crystallisation, evaporation and degradation). These 
data were combined with those gathered from TGA to 
determine the temperature for the DSC experiments. 
Differential scanning calorimetry (DSC) was carried 
out using a Q2000 DSC (TA Instruments, UK) in 
hermetically sealed Tzero aluminium pans with 2.0 ± 
0.5 mg of sample. All samples were heated to 180°C at 
10℃/min, cooled at 20℃/min, and then re-heated at 
10℃/min to characterise the generated co-amorphous 
(Table 1). 
Table 1. Temperature data for the thermal events on initial 
heating, cooling and 2nd heating cycles (DSC). 
 
Chemicals Melting 
point on 
initial 
heating (℃) 
Thermal 
events on 2nd  
heating (℃) 
Start of 
mass loss 
in TGA 
(℃) 
IND-PXC 140.6 Tg 57.6 186 
IND-PXC-
AC 
130.7 Tg 44.1 187 
IND-PXC-
CAF 
124.0 Tg 43.2, Tc 105.7, 
Tm 132.0 
180 
IND-PXC- 
CTMZ 
129.3 Tg 53.3 184 
IND-PXC-
BZD 
105.5 Tg 24.5, Tc 
(HSM) 90, Tm 
(HSM) 110 
176 
a Tg – Glass transition, Tc – Crystallisation, Tm – Melting. No 
events were recorded for crystallisation on cooling for al 
chemicals.  
RESULTS AND DISCUSSION 
It was found that the 1:1 molar ratio of IND and PXC 
formed a stable co-amorphous compound indicated 
by a single glass transition in the DSC trace. This co- 
amorphous material has a high glass transition of 
57.6⁰C. 
It was found that with the addition of a third 
component a 3-component co-amorphous mixture 
could be reliably created using a melt-cool method. 
The introduction of a third component lowered the 
glass transition in all case tested (Figure 1).  
Glass transition of ternary co-amorphous with CTMZ 
was higher than the glass transition of the co- 
amorphous with AC. Nevertheless, AC melting point 
is higher than the melting of CTMZ. It suggests that 
the melting temperature of the co-amorphous 
components is not the main factor influencing the 
system. Gordon-Taylor equation [2] applied to three 
component systems will be used to assess influence of 
mass fraction and molecular size on the stability of the 
generated co-amorphous system. 
 
Fig. 1. DSC thermogram overlay of physical mixtures re-
heating after melting and quench cooling. 
 
 
CONCLUSIONS 
The DSC data have indicated that the combination of 
piroxicam and indomethacin forms a stable co- 
amorphous compound with a high glass transition 
(57.6℃). We have shown that AC, BZD, CAF, and 
CTMZ can each be added to this mixture and are 
shown to create stable co-amorphous materials 
containing three components, although with lower 
glass transitions. The compounds with higher 
affinities towards crystallisation can be seen to 
crystalize upon reheating of the co-amorphous 
mixture. In the case of BZD, this crystallisation was 
only detected through HSM. The impact of melting 
temperature, molecular mass and tendency to 
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crystallise on generation and stability of ternary co-
amorphous system will be further evaluated. 
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